Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer?

Lancet Oncol

Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Center, Aurora, CO 80045, USA. Electronic address:

Published: May 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(24)00151-7DOI Listing

Publication Analysis

Top Keywords

mitotane friend
4
friend foe
4
foe cabozantinib
4
cabozantinib treatment
4
treatment adrenocortical
4
adrenocortical cancer?
4
mitotane
1
foe
1
cabozantinib
1
treatment
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!